216 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
AGN Allergan plc. $160.59 $53.41B Sell
Article Searches
Teva (TEVA) Stock Rises 5% on Reports of Massive Job Cuts http://www.zacks.com/stock/news/284002/teva-teva-stock-rises-5-on-reports-of-massive-job-cuts?cid=CS-ZC-FT-284002 Nov 24, 2017 - Per an Israeli news release, Teva (TEVA) is expected to lay off 4000 employees
Sphera Funds Management Ltd. Buys Cellcom Israel, Allergan PLC, Teva Pharmaceutical Industries, ... http://www.gurufocus.com/news/601832/sphera-funds-management-ltd-buys-cellcom-israel-allergan-plc-teva-pharmaceutical-industries-sells-novartis-ag-bristolmyers-squibb-company-alexion-pharmaceuticals-inc Nov 27, 2017 - Sphera Funds Management Ltd. Buys Cellcom Israel, Allergan PLC, Teva Pharmaceutical Industries, Sells Novartis AG, Bristol-Myers Squibb Company, Alexion Pharmaceuticals Inc, Stocks: MRK,PTLA,CLVS,CLLS,TSRO,SHPG,CEL,AGN,TEVA,RETA,ZGN, release date:Nov 27, 2017
Teva's New CEO Re-Shuffles Senior Management, Stock Up 7% http://www.zacks.com/stock/news/284251/tevas-new-ceo-re-shuffles-senior-management-stock-up-7?cid=CS-ZC-FT-284251 Nov 28, 2017 - Teva (TEVA) announced several organizational changes in order to save costs and improve productivity.
Anthera Pharmaceuticals: Buy The Dip https://seekingalpha.com/article/4128176-anthera-pharmaceuticals-buy-dip?source=feed_sector_healthcare Nov 28, 2017 - In this piece I reiterate my bullish outlook on Anthera as a run-up play, suggesting that readers take advantage of the recent pullback.I note that the exocrine pancreatic insufficiency market is grow
Galmed Looks To Trim Fat With 2018 Phase 2 Resolution https://seekingalpha.com/article/4128821-galmed-looks-trim-fat-2018-phase-2-resolution?source=feed_tag_israel Nov 30, 2017 - NASH represents a highly sought yet untapped $35 billion potential market space. The company is engaged in two phase 2 clinical trials evaluating safety and efficacy of lead candidate Aramchol in NASH
Will Liver Risk Stymie Allergan's Fibroid Drug? https://seekingalpha.com/article/4129385-will-liver-risk-stymie-allergans-fibroid-drug?source=feed_sector_healthcare Dec 04, 2017 - The EU is investigating whether Esmya (ulipristal acetate) is linked to liver damage.AGN's NDA for ulipristal acetate was recently approved by the FDA.The EU investigation could potentially stymie tha
NASH Stocks Brace For Shockwaves From Galectin Therapeutics Trial Results https://seekingalpha.com/article/4129548-nash-stocks-brace-shockwaves-galectin-therapeutics-trial-results?source=feed_all_articles Dec 04, 2017 - Market Void from Intercepts FDA Warning Letter.Solid Case for Efficacy in Trial Results.Negative Publicity from FX Trial Haunts Valuation.Frenzied Response to PositiveTrial Results Likely.
Wallace Weitz Boosts DXC Technology, Allergan Holdings http://www.gurufocus.com/news/605597/wallace-weitz-boosts-dxc-technology-allergan-holdings Dec 04, 2017 - Wallace Weitz Boosts DXC Technology, Allergan Holdings, Stocks: DXC,DHR,DISCA,AGN,ALSN,ACIW,MTW,AXTA,PXD, Wallace Weitz, release date:Dec 04, 2017
Levin Capital Strategies, L.p. Buys DowDuPont Inc, Walt Disney Co, Treehouse Foods Inc, Sells ... http://www.gurufocus.com/news/605836/levin-capital-strategies-lp-buys-dowdupont-inc-walt-disney-co-treehouse-foods-inc-sells-general-electric-co-ei-du-pont-de-nemours-macys-inc Dec 04, 2017 - Levin Capital Strategies, L.p. Buys DowDuPont Inc, Walt Disney Co, Treehouse Foods Inc, Sells General Electric Co, E.I. du Pont de Nemours, Macy's Inc, Stocks: DIS,THS,AGN,GM,CB,UTX,DWDP,STX,MRK,NLSN,NYRT,TPGE., release date:Dec 04, 2017
Catalyst Rich Pipelines - Strongest Biotech Plays For 2018 https://seekingalpha.com/article/4129681-catalyst-rich-pipelines-strongest-biotech-plays-2018?source=feed_all_articles Dec 05, 2017 - Small biotech catalysts may provide significant returns in 2018.Wide breath of biotech companies provides diversity within the sector.A couple large surprises on the list for traditional biotech catal

Pages: 123456...22

Page 1>

Related Companies

Name Exchange Price Mkt Cap
VRTX Vertex Pharmaceuticals Incorporated NASDAQ $160.98 $40.87B
ZTS Zoetis Inc. NYSE $80.35 $38.99B
SHPG Shire plc NASDAQ $126.67 $38.42B
CELG Celgene Corporation NASDAQ $93.85 $70.59B
REGN Regeneron Pharmaceuticals, Inc. NASDAQ $323.04 $34.79B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Allergan plc.
AGN - Google Finance https://www.google.com/finance?q=AGN Industry related info and international coverage Summary News
AGN - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=AGN Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options